(Q36106869)

12 August 2017

1 reference

title

Role of progesterone and other neuroactive steroids in anxiety disorders (English)

1 reference

12 August 2017

author name string

Jean-Michel Le Mellédo

series ordinal

1

1 reference

12 August 2017

Glen Baker

series ordinal

2

1 reference

12 August 2017

language of work or name

1 reference

1 September 2004

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

12 August 2017

published in

1 reference

12 August 2017

volume

4

1 reference

12 August 2017

issue

5

1 reference

12 August 2017

page(s)

851-860

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Quality of life in individuals with anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

The cross-national epidemiology of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings: report from the World Health Organization Collaborative Study on Psychological Problems in General Health Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Treatment of social phobia with gabapentin: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Peripheral benzodiazepine binding sites on platelet membranes are increased during diazepam treatment of anxious patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Decreased density of benzodiazepine receptors in lymphocytes of anxious patients: reversal after chronic diazepam treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Peripheral-type benzodiazepine receptors in anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Effect of medroxyprogesterone pretreatment on pentagastrin-induced panic symptoms in females with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Comparative behavioral characterization of the neuroactive steroids 3α-OH,5α-pregnan-20-one and 3α-OH,5β-pregnan-20-one in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Isoniazid-induced inhibition of GABAergic transmission enhances neurosteroid content in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Anxiolytic properties of endogenously occurring pregnanediols in two rodent models of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Pregnenolone and pregnenolone sulfate, alone and with ethanol, in mice on the plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

LY354740, a potent group II metabotropic glutamate receptor agonist prevents lactate-induced panic-like response in panic-prone rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Estrogen-induced panic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.851

21 January 2018

Identifiers

DOI

10.1586/14737175.4.5.851

1 reference

12 August 2017

1 reference